Carlsmed (CARL) news
Recent news
Carlsmed - May offer up to $250 mln in securities - SEC filing
AInvest Wire · Aug 14, 2026Carlsmed - announces CMS finalizes favorable reimbursement for Aprevo lumbar procedures in FY2027
AInvest Wire · Aug 3, 2026Carlsmed - new MS-DRG assignments and payment rates effective October 1, 2026
AInvest Wire · Aug 3, 2026Carlsmed Inc: Needham initiates coverage with buy rating; price target $17
Needham & Co. has initiated coverage on Carlsmed Inc. (NYSE: NU) with a "Buy" rating and a price target of $17.00 per share, representing 36% upside from the current stock price of $12.46. The firm highlighted Nu Holdings, a subsidiary of Carlsmed Inc., as the largest global neobank with over 135…
AInvest Wire · Jul 1, 2026EvoNexus boosts IPO to 6.25M shares from 3.75M shares
Carlsmed, Inc., a medical technology company that originated from the EvoNexus incubator program, has increased the size of its initial public offering (IPO) from 3.75 million to 6.25 million shares of common stock. The company announced the pricing of its IPO at $15.00 per share, with shares…
AInvest Wire · May 21, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
